Leg Stretching Using an Exoskeleton on Demand for People With Spasticity
Leg Stretching Using a Controllable Wearable Exoskeleton on Demand for People With Spasticity
2 other identifiers
interventional
10
1 country
1
Brief Summary
The purpose of this research study is to develop a protocol using a fully wearable, portable lower-limb exoskeleton for improving leg and walking function in people with movement disorders. The study investigates the effects of wearing the device during a set of experiments including leg stretching, treadmill walking and overground walking in muscle activity, joint motion, and gait performance. The goal is to develop an effective lower-limb strategy to restore lost leg function (e.g., range of motion) and gait ability, and improve quality of life in people with movement deficits following a neurological disorder.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 22, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedStudy Start
First participant enrolled
February 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 30, 2026
February 23, 2026
February 1, 2026
8 months
June 22, 2023
February 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
3D postures
3D postures will be assessed using the device, combining measurements of multiple joints in space
Through study completion, an average of 24 weeks
Joint angles
Hip and knee joint angles measured in degrees will be assessed using the device
Through study completion, an average of 24 weeks
Joint angular velocities
Hip and knee joint velocities measured in radians per second or degrees per second will be assessed using the device
Through study completion, an average of 24 weeks
Study Arms (1)
Robotic Exoskeleton
EXPERIMENTALAll participants will be interfered with a wearable robotic exoskeleton.
Interventions
* Participant preparation, placement of wearable sensors and monitoring, and wearable device fitting. * Lower-limb joint rotations and leg stretching protocol (40-60 minutes). The wearable exoskeleton and its control algorithm are evaluated to rotate leg joints and apply stretching similarly to the forces applied by nurses and caregivers when providing manual forces. Joint rotation and limb stretching is conducted while participants sit down (e.g., in a wheelchair, on a chair, on one side of a bed, or on a clinical mat) or lay down on a bed/mat. The protocol involves ankle plantarflexion and dorsiflexion, knee extension, hip flexion with the knee flexed, and toe flexion and extension (bilaterally) assisted by the exoskeleton, and each movement is repeated at a low-to-moderate rate of 10-30 cycles/minute. * Treadmilll and Overground Walking (60-90 minutes including rest periods) * Cool down (5-10 minutes)
Eligibility Criteria
You may qualify if:
- Veteran individuals with spasticity due to spinal cord injury (SCI) at least 6 months post SCI
- Capable of providing informed consent and reporting age, gender, and neurological condition
- Neurologically stable (\>6 months post-SCI) and can wear the device and the sensors, provide written informed consent, and follow instruction
You may not qualify if:
- Participants should not experience another neurological disorder except their primary diagnosed neurological condition (spinal cord injury)
- Participants should not be pregnant
- Participants should weigh less than 300 lbs
- Participants should not have experienced signs of hip/knee pain during the past 2-3 weeks that limits mobility (i.e., reaching, walking, lifting, etc.)
- Participants should be recovered from any previous surgical interventions, joint injuries, muscle strain, or extreme muscle soreness following surgery
- Participants should not take medications known to affect bone metabolism, muscle strength or cardiovascular performance or have any ailments causing high fever, high blood pressure, or high heart rate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- VA Office of Research and Developmentlead
- Syracuse Universitycollaborator
Study Sites (1)
Syracuse VA Medical Center, Syracuse, NY
Syracuse, New York, 13210-2716, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Steven W Brose
Syracuse VA Medical Center, Syracuse, NY
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- FED
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2023
First Posted
July 3, 2023
Study Start
February 9, 2026
Primary Completion (Estimated)
September 30, 2026
Study Completion (Estimated)
October 30, 2026
Last Updated
February 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share